Cyclica and Dalton Medicinal Chemistry Partners Announce Collaboration Agreement to Identify and Develop New Drug Candidates
4/10/2013 11:09:33 AM
More...
|
Dalton Medicinal Chemistry Partners Receives Notice of Award From National Institute on Drug Abuse (NIDA) of National Institutes of Health (NIH) to Fund Research
3/27/2013 11:49:47 AM
More...
|
BioRelix Pharmaceuticals and Dalton Medicinal Chemistry Partners Expand and Renew Research Agreement to Capitalize on Riboswitches
3/24/2009 9:08:54 AM
More...
|
BIKAM and Dalton Medicinal Chemistry PartnersSign Collaborative Research Agreement
3/4/2008 6:56:36 AM
More...
|
Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
1/23/2008 9:17:10 AM
More...
|
BioRelix, Inc. and Dalton Medicinal Chemistry Partners Sign Research Agreement to Capitalize on RiboSwitch Technology
11/14/2007 7:22:46 AM
More...
|
BioRelix, Inc. and Dalton Medicinal Chemistry Partners Medicinal Chemistry Sign Research Agreement to Capitalize on RiboSwitch Technology
11/13/2007 2:43:57 PM
More...
|
Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
10/29/2007 10:03:16 AM
More...
|